期刊文献+

低频超声开放大鼠血脑肿瘤屏障与TNF-α表达之间的关系 被引量:1

Relationship of Low Frequency Ultrasound Opening Blood-Brain Tumor Barrier with the Expression of Tumor Necrosis Factorα in Rat
暂未订购
导出
摘要 目的探讨肿瘤坏死因子-α(TNF-α)与低频超声开放大鼠血脑肿瘤屏障之间的关系。方法应用1MHz低频超声辐照C6胶质瘤大鼠,采用伊文思蓝(EB)法检测血脑肿瘤屏障通透性的变化,应用透射电镜观察脑微血管内皮细胞紧密连接的变化,应用酶联免疫吸附试验(ELISA)法检测脑组织中TNF-α含量的变化。结果低频超声辐照后大鼠血脑肿瘤屏障的通透性逐渐增加,在辐照后1.5h ̄3h达高峰,12h恢复至正常水平;透射电镜显示低频超声辐照后,0.5h至9h血管内皮细胞的紧密连接均有不同程度的开放,至12h时关闭;低频超声辐照后大鼠胶质瘤侧脑组织中TNF-α含量逐渐增加,在1.5h ̄3h达高峰,12h恢复至正常水平。结论低频超声辐照大鼠脑胶质瘤模型后引起TNF-α量的变化与血脑肿瘤屏障通透性变化的趋势及达到峰值的时间相一致。TNF-α的增加可能是低频超声辐照开放大鼠脑胶质瘤血肿瘤屏障的重要因素之一。 Objective To investigate the relationship of low frequency ultrasound opening blood-brain tumor barrier(BBTB) with the expression of tumor necrosis factor α (TNF- α ) in rat. Methods The permeablility of BBTB was measured by Evans blue(EB) assay, the status of the tight junction(TJ) of brain microvascular endothelial cell was observed with transmission electron microseope(TEM), and enzyme-linked immunosorbent assays(ELISA) was used to detect the content of TNF- α in the C6 glioma brain tissue treated with 1MHz low frequency ultrasound respectively. Results After low frequency ultrasound treatment, the permeablility of BBTB was increased gradually and reached a peak at 1.5h-3h, then restored to normal level at 12h.TEM revealed that the TJ of brain microvascular endothelial cell was destroyed, opened at 0.5h-9h, then closed at 12h. ELISA revealed that the content of TNF-α in the tumor brain tissue was increased gradually and reached a peak value at low frequency ultrasound treatment for 1.5h-3h, then decreased and restored to normal level at 12h. Conclusion Low frequency ultrasound treatment upregulates the expression of TNF- α in the tumor brain tissue and increases the permeablility of BBTB in C6 glioma rat model, TNF-α might be involved in the process of low frequency ultrasound opening the BBTB.
出处 《解剖科学进展》 CAS 2008年第4期391-394,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金(No.30570650 30670723) 教育部高等学校博士学科点专项科研基金(No.20050159005) 辽宁省自然科学基金(No.20052102) 沈阳市科学技术计划(No.1072033-1-00)
关键词 低频超声 肿瘤坏死因子-Α 血脑肿瘤屏障 大鼠 Low frequency ultrasound tumor necrosis factor α blood-brain tumor barrier rat
  • 相关文献

参考文献9

  • 1Hau P, Koch D, Hundsberger T, et al. Safety and feasibility of long term temozolomide treatment in patients with high-grade glioma[J]. Neurology, 2007, 68(9): 688-690.
  • 2Black KL, Ningaraj NS. Modulation of brain tumor capillaries for enhanceed drug delivery selectively to brain tumor[J]. Cancer Control, 2004, 11(3): 165-173.
  • 3McDannold N, Vykhodtseva N, Raymond S, et al. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits[J]. Ultrasound in MED and Biol, 2005 31(11): 1527-1537.
  • 4张震,夏春义,薛一雪,刘云会.低频超声开放大鼠血脑屏障的研究[J].解剖科学进展,2007,13(4):343-345. 被引量:6
  • 5张震,夏春义,刘云会,薛一雪.低频超声选择性开放血肿瘤屏障的实验性研究[J].中国超声医学杂志,2008,24(7):580-583. 被引量:8
  • 6Hynynen K, McDannold N, Vykhodtseva N, et al. Non-invasive opening of BBB by focused ultrasound[J]. Acta Neurochir Suppl, 2003, 86: 555-558.
  • 7Kinoshia M, McDannold N, Ferenc A, et al. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focuse ultrasound[J]. Bioche Biophy Res Commu, 2006, 340: 1085-1090.
  • 8Mark KS, Miller DW. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure[J]. Life Sci, 1999, 64(21): 1941-1953.
  • 9Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate thepermeability of an in vitro model of the human blood-brain barrier[J]. Exp Neurol, 2004, 190(2): 446-455.

二级参考文献21

共引文献9

同被引文献26

  • 1杨智航,薛一雪,刘云会,刘丽波,刘丽,张桦.神经胶质瘤nNOS和cGMP表达水平与其病理级别相关关系的研究[J].中华肿瘤防治杂志,2006,13(6):407-410. 被引量:8
  • 2DeVita VT Jr. Principles of chemotherapy[M]. In DeVita VT Jr, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oneology, ed 4. Philadelphia: 283-284.
  • 3Ikeda M, Nagashima T, Bhattacharjee AK, et al. Quantitative analysis of hyperosmotic and hypothermic blood-brain barrier opening[J]. Acta Neurochir Suppl, 2003, 86(4): 559-563.
  • 4Black KL, Baba T Pardridge WM. Enzymatic barrier protects brain capillaries from leukotriene C4[J]. J Neurosurg, 1994, 81(5): 745- 751.
  • 5Black KL, Cloughesy T, Huang SC, et al. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas[J]. J Neurosurg, 1997, 86(4): 603-609.
  • 6Sugita M, Black KL. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors[J]. Cancer Res, 1998, 58(5): 914-920.
  • 7Liu Y, Hashizume K, Chen Z, et al. Correlation between bradykinin induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors[J]. Neurol Res, 2001, 23(4): 379-387.
  • 8Ningaraj NS, Rao M, Hashizume K, et al. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels[J]. J Pharmacol ExD Ther, 2002, 301(3): 838-851.
  • 9Liu LB, Xue YX, Liu YH, et al. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton[J]. J Neurosci Res, 2008, 86(5): 1153-1168.
  • 10Wang YB, Peng C, Liu YH. Low dose of bradykinin selectively increases intracellular calcium in glioma cells[J]. J Neurol Sci, 2007, 258(1-2): 44-51.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部